TwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedActivity from announced rounds
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.